Synthetic mammalian prions

Science. 2004 Jul 30;305(5684):673-6. doi: 10.1126/science.1100195.

Abstract

Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of beta sheet-rich structures. Fibrils consisting of recMoPrP(89-230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89-231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are infectious proteins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amyloid / chemistry
  • Amyloid / metabolism
  • Animals
  • Biopolymers
  • Brain / metabolism
  • Brain / pathology
  • Brain Chemistry
  • Escherichia coli / genetics
  • Female
  • Glycosylation
  • Male
  • Mice
  • Mice, Transgenic
  • Plaque, Amyloid / pathology
  • PrPSc Proteins / analysis
  • PrPSc Proteins / metabolism
  • Prion Diseases / etiology*
  • Prion Diseases / pathology
  • Prion Diseases / transmission
  • Prions / administration & dosage
  • Prions / biosynthesis
  • Prions / chemistry
  • Prions / pathogenicity*
  • Protein Conformation
  • Protein Folding
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / chemistry
  • Time Factors
  • Tissue Extracts / administration & dosage
  • Vacuoles / pathology

Substances

  • Amyloid
  • Biopolymers
  • PrPSc Proteins
  • Prions
  • Recombinant Proteins
  • Tissue Extracts